Literature DB >> 32170822

Disseminated Mycobacterium massiliense infection in a patient with myelodysplastic syndrome undergoing allogeneic bone marrow transplantation.

Takaaki Toyama1,2, Takehiko Mori1,3, Jun Kato1, Kayoko Sugita3, Naoki Hasegawa3,4, Noboru Nakata5, Yoshihiko Hoshino6, Shinichiro Okamoto1.   

Abstract

Nontuberculous mycobacteria are ubiquitous in water and soil, and the subset of rapidly growing mycobacteria species can cause severe infections in immunocompromised patients. Solid organ or hematopoietic stem cell transplantation (HSCT) recipients are known to be susceptible to infection by nontuberculous mycobacteria. The nontuberculous mycobacteria species Mycobacterium massiliense (M massiliense) has been classified as a rapidly growing mycobacteria and recognized as a pathogen causing lung and soft tissue infections in humans. However, there have been only a few reported cases of M massiliense infection after solid organ transplantation and HSCT. We herein report another case of M massiliense infection after allogeneic HSCT, which manifested as soft tissue infection, lung infection, and bacteremia.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Mycobacterium massiliensezzm321990; allogeneic bone marrow transplantation; bacteremia; subcutaneous tissue infection

Mesh:

Substances:

Year:  2020        PMID: 32170822     DOI: 10.1111/tid.13278

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  1 in total

1.  A Disseminated Mycobacterium Abscessus Infection in a Patient Affected by Pulmonary Graft versus Host Disease: Case Report with a Revision of Literature.

Authors:  Andrea Bernardelli; Alberto Schena; Alessia Savoldi; Chiara Colato; Valentina Baretta; Emiliano D'Alessandro; Giulia Zamboni; Mehrdad Shoushtari Zadeh Naseri; Flavio Favaro; Marta Peracchi; Donatella Schena; Angelo Andreini; Simone Cesaro; Cristina Tecchio
Journal:  J Clin Med       Date:  2022-04-25       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.